SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-025015
Filing Date
2012-04-12
Accepted
2012-04-12 16:22:05
Documents
9
Period of Report
2012-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-9372_28k.htm 8-K 43967
2 EX-1.1 a12-9372_2ex1d1.htm EX-1.1 274697
3 EX-5.1 a12-9372_2ex5d1.htm EX-5.1 14013
4 EX-99.1 a12-9372_2ex99d1.htm EX-99.1 11620
5 GRAPHIC g93722kmi001.gif GRAPHIC 2462
6 GRAPHIC g93722kmi002.gif GRAPHIC 2662
7 GRAPHIC g93722kmi003.gif GRAPHIC 8347
8 GRAPHIC g93722kmi004.gif GRAPHIC 2457
9 GRAPHIC g93722mmi001.jpg GRAPHIC 3114
  Complete submission text file 0001104659-12-025015.txt   372613
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 12756679
SIC: 2834 Pharmaceutical Preparations